Neural

Longevity and the Singularity

Consciousness in the cloud? Where science fact and fiction collide. While the principle focus of Longevity is undoubtedly the extension of healthy human lifespan, there...

Making the Longevity grade: expanded list of 1000 leading names

2020 list showcases a growing network of Longevity influencers from the worlds of aging research, technology, policy, media and investment. Who's who in Longevity? Following-on...

Longevity and the art of motorcycle maintenance

OpenCures' Kevin Perrott talks about empowering the consumer with their own health data. One of the Longevity sector’s leading voices came to the field relatively...

Longevity2020: Day 3 recap

Experts, innovators, investors and the curious meet online in the biggest Longevity conference ever staged. As we enter the fourth day of Longevity2020, we thought...

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Biological and artificial neurons linked using standard IP

A world wide web that is partly biological has been created around the globe by collaborating scientists. New nanoelectronic device research has enabled both artificial and...

Some good news: announcing Longevity2020

In these challenging times, with everyone working from home and conferences pushed-back to later this year, we had an idea: Longevity2020 While the world overcomes...

Wired for sound: neuroceutical boosts immunity

Smartphone neuroceutical app harnesses the brain's quantum state to boost the immune system in the fight against aging. Quantum mechanics, the motion and interaction of...

Nutraceuticals to beat cognitive decline before it starts

Talking nutraceuticals and pharmaceuticals, trials, scaling-up and Singapore with the founder of Senescence Life Sciences. Singapore-based Senescence Life Sciences aims to use nutraceuticals to combat natural brain...

J&J enters Longevity market with “Immorbidity” play

A new competition aims to find the next great breakthrough to help us stay active and healthy beyond the age of 100. People are living...

NeuroTech Analytics releases industry-first report

New open-access analytical report profiles top technologies, sectors, trends, companies, investors, R&D hubs and influencers in the Global NeuroTech Industry “Global NeuroTech Industry Landscape Overview...

Integrating mind and machine: Closer to singularity?

The concept of technological singularity may be scary for some, and exciting for others. But, could it hold answers to a future cure for...

2020 outlook for Longevity technology

Will 2020 be the year that sees a step change in Longevity? We review technology readiness levels for key Longevity domains. Yep, we have a...

The Pentagon and Longevity tech opportunities

A released Pentagon report identifies research in areas with Longevity application - tech is moving fast and makes for intriguing reading. The US Military has...

Bioelectronics set to hit $10bn within 5 years

The growth in neural technology and cybernetic start-ups will fuel M&A activity between next year and the end of 2025. Neuralink, a company which is...

Artificial neurons created on microchip

A major breakthrough for neural technology as scientists reproduce the electrical properties of neurons on a semiconductor chip. Researchers at Bath have made a world...

Chip delivers Alzheimer’s protein direct to brain

The blood-brain barrier (BBB) can be notoriously difficult to overcome; an Israeli team have overcome this with a nanochip that carries a neurodegenerative-combatting "neural growth...

Global neural start-ups market heats-up

A slew of new technologies are entering the neural market, we're interested in those that provide a pathway to deeper neural integration. Let's take...

Scientists place human into suspended animation

Doctors have placed a patient into suspended animation in a development which offers a glimpse of a pathway to singularity. Earlier this month we reported...

Meet Peter 2.0: One step closer to the Singularity

When Dr Peter Scott-Morgan was diagnosed with motor neurone disease, he decided to challenge what it means to be human. “Peter 2.0 is now online.”...

Latest articles

VC enters Longevity market with K4Connect deal

We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity. Longevity agetech company K4Connect has announced...

Challenging the one drug/one disease model

A new paper supports the targeting of aging processes, rather than just one disease, to improve Longevity outcomes. Multimorbidity is a challenge for Longevity; defined...

Robotics and AI combine for new therapeutics discovery

Insilico Medicine and Arctoris announce robotics/AI partnership to focus on COVID-19 inhibitors that could have wide-reaching benefits for Longevity. Two companies have joined forces in...

The results are in: sharing our Longevity investment survey

There is rapidly-increasing activity in both the research and the investment communities that focus on Longevity; this survey gets into the details. The global Longevity...